1. Home
  2. BENF vs SBFM Comparison

BENF vs SBFM Comparison

Compare BENF & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BENF
  • SBFM
  • Stock Information
  • Founded
  • BENF 2003
  • SBFM 2006
  • Country
  • BENF United States
  • SBFM United States
  • Employees
  • BENF N/A
  • SBFM N/A
  • Industry
  • BENF Blank Checks
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BENF Finance
  • SBFM Health Care
  • Exchange
  • BENF Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • BENF 4.2M
  • SBFM 3.7M
  • IPO Year
  • BENF N/A
  • SBFM N/A
  • Fundamental
  • Price
  • BENF $0.62
  • SBFM $2.88
  • Analyst Decision
  • BENF
  • SBFM Strong Buy
  • Analyst Count
  • BENF 0
  • SBFM 1
  • Target Price
  • BENF N/A
  • SBFM $15.00
  • AVG Volume (30 Days)
  • BENF 362.1K
  • SBFM 143.7K
  • Earning Date
  • BENF 11-14-2024
  • SBFM 11-05-2024
  • Dividend Yield
  • BENF N/A
  • SBFM N/A
  • EPS Growth
  • BENF N/A
  • SBFM N/A
  • EPS
  • BENF N/A
  • SBFM N/A
  • Revenue
  • BENF N/A
  • SBFM $32,959,491.00
  • Revenue This Year
  • BENF N/A
  • SBFM $59.94
  • Revenue Next Year
  • BENF N/A
  • SBFM $164.69
  • P/E Ratio
  • BENF N/A
  • SBFM N/A
  • Revenue Growth
  • BENF N/A
  • SBFM 61.94
  • 52 Week Low
  • BENF $0.60
  • SBFM $2.11
  • 52 Week High
  • BENF $28.80
  • SBFM $572.00
  • Technical
  • Relative Strength Index (RSI)
  • BENF 35.49
  • SBFM 47.47
  • Support Level
  • BENF $0.60
  • SBFM $2.82
  • Resistance Level
  • BENF $0.69
  • SBFM $2.99
  • Average True Range (ATR)
  • BENF 0.05
  • SBFM 0.23
  • MACD
  • BENF 0.00
  • SBFM -0.02
  • Stochastic Oscillator
  • BENF 10.96
  • SBFM 9.95

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: